Explore more topics
News sentiment

AstraZeneca PLC (AZN) news sentiment

How positive or negative AstraZeneca PLC's news headlines have been since Sep 23, 2019, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-11-06

Average tone, last 30 sessions
+59From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
156
Headlines, last 90 sessions
509
Change from the 90-session average
+36
Latest session
2026-11-06

Weekly headline tone since September 2019

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlinesFiltered out (passing mentions)
Every week since Sep 23, 2019
AZN headline tone: Every week since Sep 23, 2019, 370 weeks from September 23, 2019 to October 26, 2026.-100-75-50-25+25+50+75+1000Headlines2020202120222023202420252026

Coverage of AstraZeneca PLC over the last 30 trading sessions is positive (+59) across 156 headlines, 21 points above its one-year average of +38. The most widely carried story in the week of Oct 26, 2026 was "Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research", carried by 9 outlets.

Each point is one week of headlines about AstraZeneca PLC: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 50,133 headlines average +14.

Jump to a section

Tone mix

AZN headlines by tone, last 52 weeks
positive
55%
neutral
29%
negative
16%

Week by week 52 weeks

Nov 3, 2025: 34 positive, 15 neutral, 7 negativeNov 10, 2025: 20 positive, 5 neutral, 0 negativeNov 17, 2025: 11 positive, 4 neutral, 2 negativeNov 24, 2025: 35 positive, 9 neutral, 1 negativeDec 1, 2025: 12 positive, 6 neutral, 1 negativeDec 8, 2025: 7 positive, 4 neutral, 0 negativeDec 15, 2025: 22 positive, 5 neutral, 2 negativeDec 22, 2025: 7 positive, 5 neutral, 4 negativeDec 29, 2025: 0 positive, 3 neutral, 1 negativeJan 5, 2026: 9 positive, 9 neutral, 1 negativeJan 12, 2026: 5 positive, 10 neutral, 7 negativeJan 19, 2026: 10 positive, 9 neutral, 1 negativeJan 26, 2026: 42 positive, 9 neutral, 0 negativeFeb 2, 2026: 36 positive, 13 neutral, 6 negativeFeb 9, 2026: 44 positive, 19 neutral, 9 negativeFeb 16, 2026: 8 positive, 5 neutral, 3 negativeFeb 23, 2026: 8 positive, 5 neutral, 1 negativeMar 2, 2026: 2 positive, 6 neutral, 1 negativeMar 9, 2026: 7 positive, 10 neutral, 2 negativeMar 16, 2026: 14 positive, 9 neutral, 2 negativeMar 23, 2026: 7 positive, 2 neutral, 0 negativeMar 30, 2026: 16 positive, 9 neutral, 2 negativeApr 6, 2026: 8 positive, 1 neutral, 1 negativeApr 13, 2026: 5 positive, 6 neutral, 1 negativeApr 20, 2026: 13 positive, 4 neutral, 3 negativeApr 27, 2026: 29 positive, 9 neutral, 14 negativeMay 4, 2026: 5 positive, 9 neutral, 3 negativeMay 11, 2026: 18 positive, 1 neutral, 2 negativeMay 18, 2026: 17 positive, 4 neutral, 1 negativeMay 25, 2026: 8 positive, 9 neutral, 9 negativeJun 1, 2026: 10 positive, 2 neutral, 6 negativeJun 8, 2026: 17 positive, 6 neutral, 0 negativeJun 15, 2026: 6 positive, 10 neutral, 1 negativeJun 22, 2026: 4 positive, 5 neutral, 1 negativeJun 29, 2026: 9 positive, 7 neutral, 5 negativeJul 6, 2026: 11 positive, 10 neutral, 22 negativeJul 13, 2026: 13 positive, 9 neutral, 8 negativeJul 20, 2026: 3 positive, 4 neutral, 4 negativeJul 27, 2026: 29 positive, 19 neutral, 9 negativeAug 3, 2026: 14 positive, 37 neutral, 25 negativeAug 10, 2026: 5 positive, 4 neutral, 4 negativeAug 17, 2026: 10 positive, 5 neutral, 11 negativeAug 24, 2026: 6 positive, 5 neutral, 2 negativeAug 31, 2026: 6 positive, 7 neutral, 2 negativeSep 7, 2026: 14 positive, 3 neutral, 4 negativeSep 14, 2026: 17 positive, 3 neutral, 14 negativeSep 21, 2026: 7 positive, 1 neutral, 0 negativeSep 28, 2026: 23 positive, 7 neutral, 0 negativeOct 5, 2026: 16 positive, 9 neutral, 2 negativeOct 12, 2026: 18 positive, 5 neutral, 3 negativeOct 19, 2026: 18 positive, 5 neutral, 1 negativeOct 26, 2026: 20 positive, 6 neutral, 1 negative
Nov 3, 2025Oct 26, 2026

Share of AstraZeneca PLC's 1,330 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 87 sessions with a headline
AZN average headline tone by session: Last 87 sessions with a headline, 87 sessions from July 2, 2026 to November 6, 2026.-100-75-50-25+25+50+75+1000HeadlinesJul 2026AugSepOctNov

Each point is the average score of the headlines about AstraZeneca PLC in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions33+52
Last 30 sessions156+59
Last 90 sessions509+24

Every headline in the period counts equally.

Headlines on Friday, November 6, 2026

1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

AstraZeneca Pharma India Limited marks continued growth and strong commercial performancewww.equitybulls.com1Positive

Headlines on Thursday, November 5, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

AstraZeneca makes $10 billion offer for obesity drugmaker Rhythm, WSJ reportsinvestinglive.com1Neutral

Headlines on Wednesday, November 4, 2026

4 headlines, average tone +25: 1 positive, 3 neutral and 0 negative. Showing all 4.

Show the table · 4 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Azerbaijan's budget revenues from customs duties to reach AZN 1.9 billion next yearen.apa.az1Positive
AstraZeneca appoints Naveen Krishna Yamarthi as Managing Director, AstraZeneca India Private Limited (AZIPL) and Head of Global Innovation & Technology Centre, Chennaiorissadiary.com1Neutral
16,079 Shares of AstraZeneca Plc $AZN Acquired by Provenance Wealth Advisors LLCwww.themarketsdaily.com1Neutral
AstraZeneca India appoints new MD and Chennai centre headwww.thehindubusinessline.com1Neutral

Headlines on Tuesday, November 3, 2026

4 headlines, average tone +12: 1 positive, 2 neutral and 1 negative. Showing all 4.

Show the table · 4 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

AstraZeneca results reassure on long-term growth as three brokers raise price targetswww.proactiveinvestors.com1Positive
Earnings roundup: AstraZeneca's cost cuts, Alnylam's slump and Regeneron's resiliencewww.biopharmadive.com1Negative
AstraZeneca India appoints new MD and Chennai centre headwww.thehindubusinessline.com1Neutral
SOFAZ reports AZN 12.34 billion in revenue for first nine months of 2026www.azernews.az1Neutral

Headlines on Monday, November 2, 2026

11 headlines, average tone +63: 7 positive, 4 neutral and 0 negative. The 8 most widely carried stories are listed; the table holds all 11.

Show the table · 11 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

AstraZeneca Stock Gaps Up To Three-Month High As CEO Calls Out $20 Billion Potentialwww.investors.com2Positive
FTSE 100 Modestly Higher; AstraZeneca Rises On Strong Earningswww.rttnews.com1Positive
AstraZeneca Q3 Profit Rises; Pipeline Delivers 12 Positive Phase 3 Readouts; Stock Upwww.rttnews.com1Positive
AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings planwww.euronews.com1Positive
FTSE 100 logs first monthly gain in three; AstraZeneca jumpswww.aol.com1Positive
Drugs giant AstraZeneca reveals higher profits, savings planthepeninsulaqatar.com1Positive
AstraZeneca CEO strikes bullish tone on pipeline as stock rallieswww.aol.com1Positive
AstraZeneca: 3 Key Takeaways for Long-Term Investorswww.fool.com1Neutral
Notable healthcare headlines for the week: Eli Lilly, Merck and AstraZeneca in focusseekingalpha.com1Neutral
AstraZeneca (NYSE:AZN) Issues Earnings Resultswww.tickerreport.com1Neutral
AstraZeneca (AZN) Q3 2026 Earnings Call Transcriptwww.fool.com1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about AstraZeneca PLC, not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.